253 related articles for article (PubMed ID: 14760795)
1. Macrophage migration inhibitory factor in systemic lupus erythematosus.
Foote A; Briganti EM; Kipen Y; Santos L; Leech M; Morand EF
J Rheumatol; 2004 Feb; 31(2):268-73. PubMed ID: 14760795
[TBL] [Abstract][Full Text] [Related]
2. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
Nossent JC
J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
[TBL] [Abstract][Full Text] [Related]
3. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
4. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
5. [The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus].
Chen WY; Li GR; Fang F; Yang X; He XS; Zhou FY; Yu XQ
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):572-5. PubMed ID: 15355659
[TBL] [Abstract][Full Text] [Related]
6. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
8. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
10. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
[TBL] [Abstract][Full Text] [Related]
11. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
12. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
13. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Petri M; Nived O; Snaith M; Sturfelt G
J Rheumatol; 2000 Feb; 27(2):373-6. PubMed ID: 10685799
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Muramaki M; Miyake H; Yamada Y; Hara I
Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
[TBL] [Abstract][Full Text] [Related]
15. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
19. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
20. [Significance of damage index in predicting systemic lupus erythematosus outcome].
Tarasova IA; Ivanova MM; Zhorniak AP; Nasonova VA
Ter Arkh; 2003; 75(1):59-62. PubMed ID: 12652960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]